{"nct_id":"NCT05530278","title":"A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic Fibrosis","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2022-09-20","start_date_type":"ACTUAL","primary_completion_date":"2022-11-29","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-29","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}